当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
标题(英文)
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
条件
Locally Advanced Lung Non-Small Cell Carcinoma|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8
干预
Drug: Cisplatin|Biological: Durvalumab|Drug: Etoposide|Radiation: Hypofractionated Radiation Therapy|Drug: Pemetrexed